These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17272797)

  • 1. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
    Foster TS
    Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
    Ziegler D; Reljanovic M; Mehnert H; Gries FA
    Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
    Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
    Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy.
    Tang J; Wingerchuk DM; Crum BA; Rubin DI; Demaerschalk BM
    Neurologist; 2007 May; 13(3):164-7. PubMed ID: 17495764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
    Hahm JR; Kim BJ; Kim KW
    J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
    Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
    Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Lipoic acid, diabetic neuropathy, and Nathan's prophecy.
    Papanas N; Maltezos E
    Angiology; 2012 Feb; 63(2):81-3. PubMed ID: 22253286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
    Tankova T; Koev D; Dakovska L
    Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
    Vereşiu IA
    Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
    Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
    Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy.
    Sachse G; Willms B
    Horm Metab Res Suppl; 1980; 9():105-7. PubMed ID: 6769773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.
    Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T
    Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
    Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
    Jin HY; Joung SJ; Park JH; Baek HS; Park TS
    Diabet Med; 2007 Sep; 24(9):1034-8. PubMed ID: 17490418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictors of alpha-lipoic acid treatment efficacy in diabetic polyneuropathy of the lower limbs].
    Bregovskiĭ VB; Posokhina OV; Karpova IA
    Ter Arkh; 2005; 77(10):15-9. PubMed ID: 16320678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for diabetic mononeuropathy with alpha-lipoic acid.
    Tankova T; Cherninkova S; Koev D
    Int J Clin Pract; 2005 Jun; 59(6):645-50. PubMed ID: 15924591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
    Ziegler D
    Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of α-lipoic acid in diabetic neuropathy.
    Papanas N; Ziegler D
    Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.